Compare BNGO & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNGO | SINT |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 11.1M |
| IPO Year | 2018 | 2007 |
| Metric | BNGO | SINT |
|---|---|---|
| Price | $1.26 | $2.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.00 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 163.2K | 34.2K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.50 | 59.45 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000,735.00 | $1,018,000.00 |
| Revenue This Year | $14.99 | $30.26 |
| Revenue Next Year | $34.73 | $413.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 26.26 | N/A |
| 52 Week Low | $1.06 | $1.99 |
| 52 Week High | $5.50 | $6.78 |
| Indicator | BNGO | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 37.94 |
| Support Level | $1.10 | $1.99 |
| Resistance Level | $1.31 | $2.46 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 61.57 | 28.00 |
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.